Publications

Find out some of the most recentpublications from our group


Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies

Cancers (Basel). 2023 Nov 16;15(22):5451
doi: 10.3390/cancers15225451 – PubMed ID: 38001711 – PMCID: PMC10670103





Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials

Eur J Cancer. 2023 Aug;
doi: 10.1016/j.ejca.2023.05.001 – PubMed ID: 37301718











Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studies

European Journal of Cancer – 2022
doi 10.1016/j.ejca.2022.04.019 – PubMed ID: 35594613



FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studies

European Journal of Cancer – 2022
doi 10.1016/j.ejca.2022.02.031 – PubMed ID: 35366570




Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications

Journal of the National Cancer Institute – 2021
doi 10.1093/jnci/djab169 – PubMed ID: 34469533



Empty section. Edit page to add content here.
Empty section. Edit page to add content here.